Aigen Investment Management’s Progyny PGNY Stock Holding History

Aigen Investment Management’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,624	Closed	-$225K	–	1015
2023 Q3	$225K	Sell	6,624 -7,005	-51%	-$264K	0.04%	632
2023 Q2	$536K	Buy	+13,629	New	+$492K	0.08%	332
2021 Q1	–	Sell	-16,511	Closed	-$700K	–	824
2020 Q4	$700K	Buy	+16,511	New	+$537K	0.09%	296

Other funds holding PGNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Aigen Investment Management's PGNY Position: Q4 2023 in Review

Aigen Investment Management sold out of Progyny (PGNY) in Q4 2023, closing a stake of 6,624 shares — an estimated $225K sold.

Aigen Investment Management first reported a position in PGNY in Q4 2020 and held it in 3 quarters. The position peaked at $700K in Q4 2020. 317 funds tracked by Wall St. Rank hold PGNY as of Q4 2023.

Aigen Investment Management reported no remaining Progyny position as of Q4 2023 after selling out during the quarter.
Aigen Investment Management sold 6,624 Progyny shares in Q4 2023, an estimated $225K.
Aigen Investment Management first reported a position in Progyny in Q4 2020 and held it in 3 quarters.
Aigen Investment Management's Progyny position peaked at $700K in Q4 2020.
317 funds tracked by Wall St. Rank held Progyny as of Q4 2023.

Based on Aigen Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.